U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07723352) titled 'Journavx to Treat Pain After Thumb Basal Joint Arthroplasty' on July 20.
Brief Summary: The purpose of this study is to find out how well suzetrigine, a newly FDA-approved non-opioid pain medication, works to relieve pain after thumb basal joint replacement surgery. The researchers believe that suzetrigine may provide effective pain relief during recovery without the use of opioid medications.
Study Start Date: July 21
Study Type: OBSERVATIONAL
Condition:
Thumb Basal Joint Osteoarthritis
Postoperative Pain
Joint Replacement Surgery
Joint Replacement
Intervention:
DRUG: suzetrigine 100mg
Participants will receive the recommend...